Sword Health is shifting healthcare from human-first to AI-first through its AI Care platform, making world-class healthcare available anytime, anywhere, while significantly reducing costs for payers, self-insured employers, national health systems, and other healthcare organizations. Sword began by reinventing pain care with AI at its core, and has since expanded into women’s health, movement health, and more recently mental health. Since 2020, more than 700,000 members across three continents have completed 10 million AI sessions, helping Sword's 1,000+ enterprise clients avoid over $1 billion in unnecessary healthcare costs. Backed by 42 clinical studies and over 44 patents, Sword Health has raised more than $500 million from leading investors, including Khosla Ventures, General Catalyst, Transformation Capital, and Founders Fund. Learn more at www.swordhealth.com.

We are seeking a Head of Product to lead the development and market launch of an exciting new initiative. This is a high-impact role where you will own the product strategy, drive execution from zero to one and beyond, and deliver an exceptional consumer experience that drives meaningful clinical outcomes and sustained member engagement.

The Head of Product will work with the General Manager to help lead Sword's new initiative through an AI-native experience. By leveraging conversational AI, personalized care pathways, and intelligent support, they will help make AI care accessible to millions of members who face months-long wait times for specialists and fragmented care experiences. This product will serve both direct-to-consumer and enterprise populations, requiring deep attention to growth, retention, and long-term engagement across 4-12 month care journeys.

This role is critical to our mission. You will shape how members experience AI care, determine which features drive sustained behavior change, and establish the product foundation to scale from launch to hundreds of thousands of members. You will work at the intersection of cutting-edge AI capabilities and direct care delivery, balancing innovation velocity with clinical rigor and regulatory requirements.